valine has been researched along with Cytomegalovirus in 47 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 2 (4.26) | 18.7374 |
| 1990's | 6 (12.77) | 18.2507 |
| 2000's | 15 (31.91) | 29.6817 |
| 2010's | 24 (51.06) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Jones, C; Khalil, A; Ville, Y | 1 |
| Bion, JF; Cowley, NJ; Ives, N; Millar, J; Moss, P; Osman, H; Owen, A; Shiels, SC; Woolley, R | 1 |
| Baeten, JM; Corey, L; Diem, K; Huang, ML; Johnston, C; Magaret, A; Ocbamichael, N; Perti, T; Saracino, M; Selke, S; Wald, A | 1 |
| Benoist, G; Jacquemard, F; Leruez-Ville, M; Magny, JF; Salomon, LJ; Ville, Y | 1 |
| Beersma, MF; Bouts, AH; Cornelissen, EA; Cransberg, K; Jongsma, H | 1 |
| Dong, LQ; Guan, LB; Li, SF; Wang, W; Yu, P; Zhang, L; Zhang, P; Zhou, S | 1 |
| Flaxel, CJ; Lauer, AK; Yeh, S | 1 |
| Asbjörnsdóttir, K; Atkinson, C; Boeckh, M; Drake, AL; Emery, V; Farquhar, C; John-Stewart, G; Kiarie, JN; Richardson, B; Roxby, AC; Slyker, JA; Wald, A | 1 |
| Hirano, T; Tsuda, H; Tsuji, T; Yamasaki, H | 1 |
| Bouda, M; Hes, O; Jindra, P; Kacer, M; Lysak, D; Reischig, T | 1 |
| Bouda, M; Kacer, M; Kielberger, L; Reischig, T | 1 |
| Kavasoglu, K; Kervan, U; Kocabeyoglu, SS; Kucuker, SA; Ozatik, MA; Pac, M; Sert, DE; Tezer, AY; Unal, EU | 1 |
| Chanouzas, D; Dyall, L; Ferro, C; Harper, L; Morgan, MD; Moss, P; Nightingale, P | 1 |
| De Santis, M; Straface, G; Zanardo, V | 1 |
| Bowlin, TL; Drach, JC; Prichard, MN; Wu, Z; Yanachkov, I; Yanachkova, M; Zemlicka, J | 1 |
| Bouda, M; Hes, O; Jindra, P; Nemcová, J; Reischig, T; Treska, V; Vanecek, T | 1 |
| Chiang, CC; Lin, TH; Tien, PT; Tsai, YY | 1 |
| Cohney, SJ; Nicholls, K; Tan, MB; Toussaint, ND; Walker, RG | 1 |
| Borysko, K; Breitenbach, J; Drach, JC; Hilfinger, J; Kashemirov, BA; Kijek, P; Kim, JS; McKenna, CE; Mitchell, S; Peterson, LW | 1 |
| Bouda, M; Jindra, P; Lysak, D; Matejovic, M; Prucha, M; Reischig, T; Sedlackova, L | 1 |
| Abd-Alla, AM; Adun, H; Bergoin, M; Parker, AG; Vreysen, MJ | 1 |
| Brennan, DC; Santos, RD | 1 |
| Bouda, M; Hes, O; Hribova, P; Jindra, P; Reischig, T; Treska, V; Viklicky, O | 1 |
| Alexopoulos, SP; Lindberg, L; Matsuoka, L; Subramanyan, RK | 1 |
| Döhler, B; Eriksson, BM; Opelz, G; Sund, F; Tufveson, G | 1 |
| Zaia, JA | 1 |
| Chandrasekar, PH; Petersen, FB; Snydman, DR; Territo, MC; Winston, DJ; Yeager, AM | 1 |
| Alain, S; Champier, G; Cogne, N; De Wilde, A; Denis, F; Fillet, AM; Gouarin, S; Hantz, S; Imbert, BM; Karras, A; Legendre, C; Mazeron, MC; Mengelle, C; Rogez, S; Scieux, C; Szelag, JC | 1 |
| Beard, SM; Crochard, A; Durand-Zaleski, I; Lebranchu, Y; Legendre, C; Pouteil-Noble, C; Richter, A | 1 |
| Alain, S; Bensman, A; Champier, G; Dehee, A; Denis, F; Fillet, AM; Guigonis, V; Hantz, S; Mazeron, MC; Mertens, T; Michel, D | 1 |
| Morton, CJ; Ng, HL; Parker, MW; Rawlinson, WD; Scott, GM | 1 |
| Chan, KP; Kumarasinghe, G; Yap, HK; Yeo, AC | 1 |
| Chen, L; Ng, AP; Prince, HM; Seymour, JF; Slavin, M; Thursky, K; Worth, L | 1 |
| Jindra, P; Kormunda, S; Opatrný, K; Reischig, T; Svecová, M; Treska, V | 1 |
| Chihara, H; Hara, Y; Inatomi, T; Kawasaki, S; Kinoshita, S; Koizumi, N; Mochida, C; Ohashi, Y; Shiraishi, A; Sotozono, C; Suzuki, T; Uno, T; Yamasaki, K | 1 |
| Hes, O; Jindra, P; Klaboch, J; Reischig, T; Svecová, M; Treska, V | 1 |
| Bowen, EF; Davey, CC; Emery, VC; Griffiths, PD; Johnson, MA | 1 |
| Ansari, A; Dix, L; Emery, VC; Feinberg, JE; Fry, J; Gor, D; Griffiths, PD; Sabin, C | 1 |
| Chou, S; Drew, WL; Gordon, SM; LaVoy, AG; Marousek, G; Miner, RC; Parenti, DM; Ross, JG | 1 |
| Brennan, PJ; Coggon, GL; Crisp, A; Keating, MR; Kovarik, J; Lee, IC; Legendre, CM; Lowance, D; Mendez, R; Neumayer, HH; Norman, D; Squifflet, JP | 1 |
| Emery, VC; Feinberg, JE; Griffiths, PD; Grywacz, M; Knight, S; Sabin, C | 1 |
| Legendre, C | 1 |
| Feinberg, J | 1 |
| Crisp, A; de La Camara, R; Ljungman, P; Milpied, N; Russell, CA; Volin, L; Webster, A | 1 |
| De Gruttola, V; Emery, VC; Feinberg, JE; Griffiths, P; Holland, F; Jacobson, MA; Nokta, MA; Pollard, RB | 1 |
| Bouley, JP; Genevaux, M; Pinck, L; Pinck, M | 1 |
| Hall, TC; Kohl, RJ | 1 |
3 review(s) available for valine and Cytomegalovirus
| Article | Year |
|---|---|
Congenital cytomegalovirus infection: management update.
Topics: Acyclovir; Antiviral Agents; Clinical Trials, Phase II as Topic; Cytomegalovirus; Cytomegalovirus Infections; Double-Blind Method; Female; Fetal Diseases; Humans; Immunoglobulins; Infant, Newborn; Infectious Disease Transmission, Vertical; Pregnancy; Pregnancy Complications, Infectious; Randomized Controlled Trials as Topic; Valacyclovir; Valine | 2017 |
Management of pregnancies with confirmed cytomegalovirus fetal infection.
Topics: Acyclovir; Amniocentesis; Amniotic Fluid; Antiviral Agents; Congenital Abnormalities; Cytomegalovirus; Cytomegalovirus Infections; Decision Trees; Female; Fetal Diseases; Humans; Infant, Newborn; Male; Pregnancy; Prognosis; Severity of Illness Index; Ultrasonography; Valacyclovir; Valine | 2013 |
Lessons from the natural history of cytomegalovirus.
Topics: Acyclovir; Administration, Oral; AIDS-Related Opportunistic Infections; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Cytomegalovirus Retinitis; Ganciclovir; Humans; Polymerase Chain Reaction; Risk Factors; Valacyclovir; Valine | 1996 |
15 trial(s) available for valine and Cytomegalovirus
| Article | Year |
|---|---|
Safety and Efficacy of Antiviral Therapy for Prevention of Cytomegalovirus Reactivation in Immunocompetent Critically Ill Patients: A Randomized Clinical Trial.
Topics: Acyclovir; Adult; Aged; Antiviral Agents; Critical Illness; Cytomegalovirus; Cytomegalovirus Infections; Drug Administration Schedule; Female; Humans; Male; Middle Aged; Opportunistic Infections; Respiration, Artificial; Valacyclovir; Valine; Virus Activation; Virus Inactivation | 2017 |
High-dose valacyclovir decreases plasma HIV-1 RNA more than standard-dose acyclovir in persons coinfected with HIV-1 and HSV-2: a randomized crossover trial.
Topics: Acyclovir; Adult; Antiviral Agents; Coinfection; Cross-Over Studies; Cytomegalovirus; DNA, Viral; Female; Herpes Genitalis; Herpesvirus 2, Human; HIV Infections; HIV-1; Humans; Male; Middle Aged; Patient Compliance; RNA, Viral; Valacyclovir; Valine; Viral Load; Virus Shedding | 2013 |
Maternal valacyclovir and infant cytomegalovirus acquisition: a randomized controlled trial among HIV-infected women.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; HIV Seropositivity; Humans; Infant; Infant, Newborn; Infectious Disease Transmission, Vertical; Milk, Human; Pregnancy; Premedication; Treatment Outcome; Valacyclovir; Valine; Viral Load; Virus Shedding | 2014 |
Randomized trial of valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation.
Topics: Acute Disease; Acyclovir; Adult; Antiviral Agents; Biomarkers; Biopsy; Cytomegalovirus; Cytomegalovirus Infections; Czech Republic; DNA, Viral; Drug Administration Schedule; Female; Ganciclovir; Graft Rejection; Graft Survival; Humans; Immunosuppressive Agents; Intention to Treat Analysis; Kidney Transplantation; Male; Middle Aged; Time Factors; Treatment Outcome; Valacyclovir; Valganciclovir; Valine; Viral Load | 2015 |
Valaciclovir to prevent Cytomegalovirus mediated adverse modulation of the immune system in ANCA-associated vasculitis (CANVAS): study protocol for a randomised controlled trial.
Topics: Acyclovir; Anti-Neutrophil Cytoplasmic Antibody-Associated Vasculitis; Antiviral Agents; CD4 Lymphocyte Count; CD4-Positive T-Lymphocytes; Clinical Protocols; Cytomegalovirus; Cytomegalovirus Infections; England; Host-Pathogen Interactions; Humans; Proof of Concept Study; Prospective Studies; Research Design; Time Factors; Treatment Outcome; Valacyclovir; Valine; Viral Load; Virus Activation | 2016 |
Intragraft cytomegalovirus infection: a randomized trial of valacyclovir prophylaxis versus pre-emptive therapy in renal transplant recipients.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Double-Blind Method; Ganciclovir; Graft Rejection; Humans; Kidney Transplantation; Postoperative Complications; Premedication; Risk Factors; Transplantation, Homologous; Treatment Outcome; Valacyclovir; Valganciclovir; Valine; Viremia | 2010 |
Long-term outcomes of pre-emptive valganciclovir compared with valacyclovir prophylaxis for prevention of cytomegalovirus in renal transplantation.
Topics: Acyclovir; Adult; Antiviral Agents; Atrophy; Biopsy; Cytomegalovirus; Cytomegalovirus Infections; Female; Fibrosis; Follow-Up Studies; Ganciclovir; Graft Survival; Humans; Kaplan-Meier Estimate; Kidney; Kidney Transplantation; Longitudinal Studies; Male; Middle Aged; Treatment Outcome; Valacyclovir; Valganciclovir; Valine | 2012 |
Randomized comparison of oral valacyclovir and intravenous ganciclovir for prevention of cytomegalovirus disease after allogeneic bone marrow transplantation.
Topics: Acyclovir; Administration, Oral; Adolescent; Adult; Aged; Antiviral Agents; Bacterial Infections; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Injections, Intravenous; Male; Microbial Sensitivity Tests; Middle Aged; Mycoses; Sepsis; Survival Analysis; Transplantation, Homologous; Valacyclovir; Valine | 2003 |
The impact of cytomegalovirus disease and asymptomatic infection on acute renal allograft rejection.
Topics: Acute Disease; Acyclovir; Antiviral Agents; Carrier State; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Graft Rejection; Humans; Incidence; Kidney Transplantation; Male; Middle Aged; Multivariate Analysis; Postoperative Complications; Prospective Studies; Risk Factors; Treatment Outcome; Valacyclovir; Valine | 2006 |
Valacyclovir prophylaxis versus preemptive valganciclovir therapy to prevent cytomegalovirus disease after renal transplantation.
Topics: Acyclovir; Adult; Aged; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Czech Republic; Ganciclovir; Humans; Incidence; Kidney Transplantation; Middle Aged; Prospective Studies; Valacyclovir; Valganciclovir; Valine | 2008 |
The effect of valaciclovir on cytomegalovirus viremia and viruria detected by polymerase chain reaction in patients with advanced human immunodeficiency virus disease. AIDS Clinical Trials Group Protocol 204/Glaxo Wellcome 123-014 International CMV Prophy
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Double-Blind Method; Female; Humans; Male; Multivariate Analysis; Polymerase Chain Reaction; Prognosis; Valacyclovir; Valine; Viremia | 1998 |
Valacyclovir for the prevention of cytomegalovirus disease after renal transplantation. International Valacyclovir Cytomegalovirus Prophylaxis Transplantation Study Group.
Topics: Acyclovir; Adult; Antiviral Agents; Cadaver; Cytomegalovirus; Cytomegalovirus Infections; Double-Blind Method; Female; Graft Rejection; Health Resources; Humans; Incidence; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prodrugs; Serologic Tests; Valacyclovir; Valine | 1999 |
Quantitative effects of valacyclovir on the replication of cytomegalovirus (CMV) in persons with advanced human immunodeficiency virus disease: baseline CMV load dictates time to disease and survival. The AIDS Clinical Trials Group 204/Glaxo Wellcome 123-
Topics: Acyclovir; AIDS-Related Opportunistic Infections; Analysis of Variance; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Disease-Free Survival; HIV Infections; Humans; Multivariate Analysis; Polymerase Chain Reaction; Prodrugs; Risk Factors; Survival Rate; Time Factors; Valacyclovir; Valine; Virus Replication | 1999 |
Randomized study of valacyclovir as prophylaxis against cytomegalovirus reactivation in recipients of allogeneic bone marrow transplants.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Bone Marrow Transplantation; Cytomegalovirus; Cytomegalovirus Infections; Double-Blind Method; Female; Humans; Male; Middle Aged; Prodrugs; Survival Analysis; Therapeutic Equivalency; Transplantation, Homologous; Valacyclovir; Valine; Virus Activation | 2002 |
Cytomegalovirus (CMV) polymerase chain reaction profiles in individuals with advanced human immunodeficiency virus infection: relationship to CMV disease.
Topics: Acyclovir; Adult; AIDS-Related Opportunistic Infections; Case-Control Studies; Cytomegalovirus; Cytomegalovirus Infections; HIV Infections; Humans; Male; Multivariate Analysis; Polymerase Chain Reaction; Predictive Value of Tests; Risk Factors; Valacyclovir; Valine | 2002 |
29 other study(ies) available for valine and Cytomegalovirus
| Article | Year |
|---|---|
Cytomegalovirus prophylaxis in pediatric kidney transplantation: the Dutch experience.
Topics: Acyclovir; Adolescent; Antiviral Agents; Child; Child, Preschool; Cytomegalovirus; Cytomegalovirus Infections; Disease-Free Survival; Ganciclovir; Humans; Immunoglobulins; Immunosuppressive Agents; Infant; Kidney Transplantation; Netherlands; Polymerase Chain Reaction; Receptors, Interleukin-2; Renal Insufficiency; Retrospective Studies; Risk; Valacyclovir; Valganciclovir; Valine | 2013 |
Prophylaxis of human cytomegalovirus infection in renal transplant patients with valacyclovir and ganciclovir.
Topics: Acyclovir; Adult; Allografts; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Valacyclovir; Valine | 2013 |
Combination systemic and intravitreal antiviral therapy in the management of acute retinal necrosis syndrome (an American Ophthalmological Society thesis).
Topics: 2-Aminopurine; Acyclovir; Administration, Oral; Adult; Antiviral Agents; Aqueous Humor; Cytomegalovirus; DNA, Viral; Drug Therapy, Combination; Eye Infections, Viral; Famciclovir; Female; Humans; Injections, Intravenous; Intravitreal Injections; Male; Middle Aged; Polymerase Chain Reaction; Retinal Detachment; Retinal Necrosis Syndrome, Acute; Retrospective Studies; Simplexvirus; Treatment Outcome; Valacyclovir; Valine; Visual Acuity; Vitreous Body | 2013 |
[Cytomegalovirus mononucleosis complicated with peripheral facial palsy].
Topics: Acyclovir; Adult; Antibodies, Viral; Antiviral Agents; Biomarkers; Cytomegalovirus; Cytomegalovirus Infections; Facial Paralysis; Female; Humans; Immunoglobulin M; Infectious Mononucleosis; Phosphoproteins; Prednisolone; Treatment Outcome; Valacyclovir; Valine; Viral Matrix Proteins | 2014 |
Valganciclovir versus valacyclovir prophylaxis for prevention of cytomegalovirus: an economic perspective.
Topics: Acyclovir; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; Follow-Up Studies; Ganciclovir; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Valacyclovir; Valganciclovir; Valine | 2015 |
Low-Dose Valacyclovir for Cytomegalovirus Infection Prophylaxis After a Heart Transplant.
Topics: Acyclovir; Adolescent; Adult; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Administration Schedule; Drug Therapy, Combination; Female; Heart Transplantation; Humans; Immunocompromised Host; Immunosuppressive Agents; Male; Middle Aged; Opportunistic Infections; Pneumonia, Viral; Risk Factors; Time Factors; Treatment Outcome; Valacyclovir; Valine; Virus Activation; Young Adult | 2016 |
Efficacy of oral valacyclovir in cytomegalovirus-infected fetuses.
Topics: Acyclovir; Administration, Oral; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Fetus; Humans; Valacyclovir; Valine | 2017 |
L-valine ester of cyclopropavir: a new antiviral prodrug.
Topics: Animals; Antiviral Agents; Biological Availability; Cyclopropanes; Cytomegalovirus; Esters; Ganciclovir; Guanine; Humans; Hydrolysis; Mice; Prodrugs; Valganciclovir; Valine; Virus Replication | 2009 |
Atypical presentation of cytomegalovirus endotheliitis: a case report.
Topics: Acyclovir; Aged; Antiviral Agents; Corneal Edema; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Endothelium, Corneal; Ganciclovir; Humans; Intraocular Pressure; Keratitis, Herpetic; Male; Prednisolone; Valacyclovir; Valganciclovir; Valine; Visual Acuity | 2011 |
Low-dose valaciclovir and cytomegalovirus immunoglobulin to prevent cytomegalovirus disease in high-risk renal transplant recipients.
Topics: Acyclovir; Adolescent; Adult; Aged; Cytomegalovirus; Cytomegalovirus Infections; Humans; Immunoglobulins; Incidence; Kidney Transplantation; Male; Middle Aged; Retrospective Studies; Tissue Donors; Valacyclovir; Valine; Young Adult | 2011 |
Synthesis, transport and antiviral activity of Ala-Ser and Val-Ser prodrugs of cidofovir.
Topics: Administration, Oral; Alanine; Animals; Antiviral Agents; Cells, Cultured; Cidofovir; Cytomegalovirus; Cytosine; Disease Models, Animal; Dose-Response Relationship, Drug; Humans; Inhibitory Concentration 50; Molecular Structure; Organophosphonates; Peptides; Prodrugs; Rats; Serine; Valine | 2011 |
Valganciclovir prophylaxis against cytomegalovirus impairs lymphocyte proliferation and activation in renal transplant recipients.
Topics: Acyclovir; Adult; Antiviral Agents; Cell Proliferation; Cells, Cultured; Concanavalin A; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Graft Rejection; Graft Survival; Humans; Immunosuppression Therapy; Immunosuppressive Agents; Kidney Transplantation; Lymphocyte Activation; Lymphocyte Count; Male; Middle Aged; Phytohemagglutinins; T-Lymphocyte Subsets; Valacyclovir; Valganciclovir; Valine | 2011 |
The antiviral drug valacyclovir successfully suppresses salivary gland hypertrophy virus (SGHV) in laboratory colonies of Glossina pallidipes.
Topics: Acyclovir; Animals; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Tsetse Flies; Valacyclovir; Valine | 2012 |
Randomized trial of pre-emptive or prophylactic valganciclovir therapy for prevention of cytomegalovirus infection in renal transplantation.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; Ganciclovir; Humans; Kidney Transplantation; Male; Valacyclovir; Valganciclovir; Valine | 2012 |
Cytomegalovirus prophylaxis in solid organ transplantation.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; Graft Rejection; Humans; Immunity, Cellular; Immunosuppressive Agents; Risk Factors; Tissue Transplantation; Valacyclovir; Valganciclovir; Valine | 2012 |
Clinical outcome with low-dose valacyclovir in high-risk renal transplant recipients: a 10-year experience.
Topics: Acyclovir; Adult; Antibiotic Prophylaxis; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Female; Follow-Up Studies; Glomerular Filtration Rate; Graft Rejection; Graft Survival; Humans; Kidney Transplantation; Male; Middle Aged; Postoperative Complications; Prognosis; Renal Insufficiency, Chronic; Retrospective Studies; Survival Rate; Time Factors; Valacyclovir; Valine | 2013 |
Prevention of cytomegalovirus disease in hematopoietic stem cell transplantation.
Topics: Acyclovir; Antiviral Agents; Chemoprevention; Cidofovir; Cytomegalovirus; Cytomegalovirus Infections; Cytosine; Ganciclovir; Hematopoietic Stem Cell Transplantation; Humans; Organophosphonates; Organophosphorus Compounds; Postoperative Complications; Risk Factors; Transplantation, Autologous; Transplantation, Homologous; Valacyclovir; Valganciclovir; Valine | 2002 |
Detection of ganciclovir resistance after valacyclovir-prophylaxis in renal transplant recipients with active cytomegalovirus infection.
Topics: Acyclovir; Amino Acid Substitution; Antiviral Agents; Chemoprevention; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Female; Ganciclovir; Humans; Kidney Transplantation; Middle Aged; Phosphoproteins; Phosphotransferases (Alcohol Group Acceptor); Pilot Projects; Retrospective Studies; Valacyclovir; Valine; Viral Matrix Proteins | 2004 |
The cost-effectiveness of prophylaxis with valaciclovir in the management of cytomegalovirus after renal transplantation.
Topics: Acyclovir; Antiviral Agents; Cost-Benefit Analysis; Cytomegalovirus; Cytomegalovirus Infections; Humans; Immunocompromised Host; Kidney Transplantation; Valacyclovir; Valine | 2005 |
Early selection of a new UL97 mutant with a severe defect of ganciclovir phosphorylation after valaciclovir prophylaxis and short-term ganciclovir therapy in a renal transplant recipient.
Topics: Acyclovir; Adolescent; Antiviral Agents; Chemoprevention; Codon; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Viral; Ganciclovir; Humans; Kidney Transplantation; Molecular Sequence Data; Phosphorylation; Phosphotransferases (Alcohol Group Acceptor); Sequence Deletion; Valacyclovir; Valine | 2005 |
Murine cytomegalovirus resistant to antivirals has genetic correlates with human cytomegalovirus.
Topics: Acyclovir; Adenine; Animals; Antiviral Agents; Cidofovir; Cytomegalovirus; Cytosine; DNA-Directed DNA Polymerase; Drug Resistance, Viral; Ganciclovir; Guanine; Humans; Mice; Models, Molecular; Molecular Sequence Data; Muromegalovirus; Mutation; Organophosphonates; Protein Kinases; Sequence Alignment; Valacyclovir; Valine; Virus Replication | 2005 |
Rapid detection of codon 460 mutations in the UL97 gene of ganciclovir-resistant cytomegalovirus clinical isolates by real-time PCR using molecular beacons.
Topics: Amino Acid Substitution; Antiviral Agents; Codon; Cytomegalovirus; DNA, Viral; Drug Resistance, Viral; Ganciclovir; Humans; Methionine; Phosphotransferases (Alcohol Group Acceptor); Point Mutation; Polymerase Chain Reaction; Polymorphism, Restriction Fragment Length; Valine | 2005 |
Cytomegalovirus DNAemia and disease: incidence, natural history and management in settings other than allogeneic stem cell transplantation.
Topics: Acyclovir; Adult; Aged; Alemtuzumab; Antibodies, Monoclonal; Antibodies, Monoclonal, Humanized; Antibodies, Monoclonal, Murine-Derived; Antibodies, Neoplasm; Antimetabolites, Antineoplastic; Antineoplastic Combined Chemotherapy Protocols; Antiviral Agents; Cohort Studies; Cyclophosphamide; Cytomegalovirus; Cytomegalovirus Infections; Dexamethasone; Diphtheria Toxin; DNA, Viral; Doxorubicin; Female; Fever; Follow-Up Studies; Ganciclovir; Hematologic Neoplasms; Humans; Interleukin-2; Male; Middle Aged; Peripheral Blood Stem Cell Transplantation; Polymerase Chain Reaction; Recombinant Fusion Proteins; Retrospective Studies; Rituximab; Transplantation, Autologous; Valacyclovir; Valine; Vidarabine; Vincristine; Viremia; Virus Activation | 2005 |
Cytomegalovirus as an etiologic factor in corneal endotheliitis.
Topics: Acyclovir; Administration, Topical; Aged; Aged, 80 and over; Antiviral Agents; Aqueous Humor; Cell Count; Cytomegalovirus; Cytomegalovirus Infections; DNA, Viral; Endothelium, Corneal; Eye Infections, Viral; Female; Ganciclovir; Humans; Keratitis; Male; Middle Aged; Polymerase Chain Reaction; Retrospective Studies; Valacyclovir; Valine | 2008 |
Mutation in region III of the DNA polymerase gene conferring foscarnet resistance in cytomegalovirus isolates from 3 subjects receiving prolonged antiviral therapy.
Topics: Adult; AIDS-Related Opportunistic Infections; Alanine; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Retinitis; DNA-Directed DNA Polymerase; Drug Resistance, Microbial; Foscarnet; Ganciclovir; Humans; Male; Phosphotransferases (Alcohol Group Acceptor); Point Mutation; Reverse Transcriptase Inhibitors; Valine; Viral Proteins | 1998 |
Ganciclovir-resistant cytomegalovirus.
Topics: Acyclovir; Antiviral Agents; Cytomegalovirus; Cytomegalovirus Infections; Drug Resistance, Microbial; Ganciclovir; Humans; Organ Transplantation; Postoperative Complications; Valacyclovir; Valine | 2000 |
The status of CMV viral load testing.
Topics: Acyclovir; Administration, Oral; Antiviral Agents; CD4 Lymphocyte Count; Cytomegalovirus; Cytomegalovirus Infections; Ganciclovir; HIV Infections; Humans; Polymerase Chain Reaction; Prospective Studies; Valacyclovir; Valine; Viral Load; Viremia | 1996 |
Amino acid acceptor activity of replicative form from some Tymovirus RNA's.
Topics: Cytomegalovirus; Mosaic Viruses; Plant Viruses; RNA Viruses; RNA, Viral; Valine; Virus Replication | 1975 |
Aminoacylation of RNA from several viruses: amino acid specificity and differential activity of plant, yeast and bacterial synthetases.
Topics: Amino Acyl-tRNA Synthetases; Cytomegalovirus; Escherichia coli; Histidine; Mosaic Viruses; Plant Viruses; Plants; RNA Viruses; RNA, Viral; Saccharomyces cerevisiae; Tobacco Mosaic Virus; Tyrosine; Valine | 1974 |